The role of proliferator-activated receptor gamma coactivator-1 alpha in the fatty-acid -dependent transcriptional control of interleukin-10 in hepatic cells of rodents


Autoria(s): MORARI, Joseane; TORSONI, Adriana S.; ANHE, Gabriel F.; ROMAN, Erika A.; CINTRA, Dennys E.; WARD, Laura S.; BORDIN, Silvana; VELLOSO, Licio A.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2010

Resumo

Interleukin-10 (IL-10) is an endogenous factor that restrains hepatic insulin resistance in diet-induced steatosis Reducing IL-10 expression increases proinflammatory activity in the steatotic liver and worsens insulin resistance As the transcriptional coactivator proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) plays a central role in dysfunctional hepatocytic activity in diet-induced steatosis, we hypothesized that at least part of the action of PGC-1 alpha could be mediated by reducing the transcription of the IL-10 gene Here, we used immunoblotting, real-time polymerase chain reaction, immunocytochemistry, and chromatin immunoprecipitation assay to investigate the role of PGC-1 alpha in the control of IL-10 expression in hepatic cells First, we show that, in the intact steatotic liver, the expressions of IL-10 and PGC-1 alpha are increased Inhibiting PGC-1 alpha expression by antisense oligonucleotide increases IL-10 expression and reduces the steatotic phenotype. In cultured hepatocytes, the treatment with saturated and unsaturated fatty acids increased IL-10 expression. This was accompanied by increased association of PGC-1 alpha with c-Maf and p50-nuclear factor (NF) kappa B, 2 transcription factors known to modulate IL-10 expression In addition, after fatty acid treatment. PGC-1 alpha, c-Maf, and p50-NF kappa B migrate from the cytosol to the nuclei of hepatocytes and bind to the IL-10 promoter region Inhibiting NF kappa B activation with salicylate reduces IL-10 expression and the association of PGC-1 alpha with p50-NF kappa B Thus, PGC-1 alpha emerges as a potential transcriptional regulator of the inflammatory phenomenon taking place in the steatotic liver (C) 2010 Elsevier Inc All rights reserved

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo

CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Identificador

METABOLISM-CLINICAL AND EXPERIMENTAL, v.59, n.2, p.215-223, 2010

0026-0495

http://producao.usp.br/handle/BDPI/28046

10.1016/j.metabol.2009.07.020

http://dx.doi.org/10.1016/j.metabol.2009.07.020

Idioma(s)

eng

Publicador

W B SAUNDERS CO-ELSEVIER INC

Relação

Metabolism-clinical and Experimental

Direitos

restrictedAccess

Copyright W B SAUNDERS CO-ELSEVIER INC

Palavras-Chave #NF-KAPPA-B #IL-10 GENE-EXPRESSION #LIVER-DISEASE #C-MAF #NONALCOHOLIC STEATOHEPATITIS #GLUCOSE #MACROPHAGES #STEATOSIS #DIET #MICE #Endocrinology & Metabolism
Tipo

article

original article

publishedVersion